West Virginia House Bill HB2099

West Virginia 2025 Regular Session

• Introduced: 2/12/25
• Refer: 2/12/25

Caption

Relating generally to drug testing of state legislators

Summary

House Bill 2099 would require the Legislative Manager to create a program for random drug testing of members of the West Virginia Legislature during each regular session. The bill applies to all legislators and directs that testing procedures be established for random selection, administration of tests, and limits on how often a legislator may be tested in a session, generally no more than twice unless a second test is required after an initial positive result. If a legislator’s first test indicates illegal drug use, the member must take a second test 30 to 60 days later. If the second test is also positive, or if the legislator refuses or fails to participate, that information must be made public. All other test results are to remain confidential. The bill’s stated purpose is to require random drug testing of legislators and to balance confidentiality with public disclosure in cases of confirmed positive results or nonparticipation.

Impact

The bill would add a new section, §4-1-24, to the West Virginia Code and create a new administrative duty for the Legislative Manager to operate and oversee a drug-testing program for legislators. It would impose a confidentiality regime for test results while creating a public disclosure requirement for repeat positive tests or refusal to test, affecting the privacy expectations and public accountability of elected officials. The measure would not directly change criminal law or substance-control statutes, but it would establish a legislative ethics/fitness-related compliance process within the operations of the Legislature.

Sentiment

Based on the bill text and the absence of recorded committee debate or votes, the available context suggests the proposal is framed as a transparency and accountability measure rather than a punitive one. The bill’s structure indicates an intent to protect confidentiality except where results are confirmed or a legislator declines to participate, which may appeal to supporters concerned with public trust. However, because no committee transcripts or vote history are provided, there is no documented consensus or opposition in the available record.

Contention

The main points of contention are likely to be privacy, due process, and the scope of legislative oversight versus public accountability. Supporters would likely emphasize that elected officials should be held to a high standard and that public disclosure is appropriate after a confirmed positive result or refusal to comply. Opponents may argue that random testing of legislators is intrusive, could raise constitutional or employment-related concerns, and may be unnecessary absent individualized suspicion. The bill also creates a tension between confidentiality and mandatory disclosure that could be debated as a matter of fairness and deterrence.